Insider share sales without purchases in the past year raise caution. Reasonable but not high insider ownership, coupled with recent selling, makes the stock less appealing to potential investors.
The stock is seen as a bargain based on a price multiple model. The company's future looks promising with increased cash flow expected, potentially leading to a higher share valuation. The current share price may not fully capture the positive future profit outlook, indicating it could be a good time to invest or increase holdings in the stock.
Despite Primoris Services' positive earnings growth, its P/E ratio is lower than the market, suggesting shareholders may doubt the forecasts. Unobserved threats to earnings may prevent the P/E ratio from matching the outlook.
Analysts commend Primoris Services' performance, particularly its investment into the business and return rate resulting in respectable earnings growth. Industry forecasts reveal expectations of the company's earnings accelerating in the future.
Insider selling activities with no purchases in past year, especially in the last three months, raise caution about the company. Low insider ownership, company's growth in earnings, and lack of insider buying suggest a level of concern for prospective investors.
71750344 :
Is NIO still a buy? There has been so much dissing of NIO, I can’t figure out why. I own several shares of NIO and watched my successful choice and investment really dwindle in value.
Gainers: •$Resolute Forest Products(RFP.US)$+65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right) •$Applied Molecular(AMTI.US)$+2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101) •$プリモリス・サービシズ(PRIM.US)$+2.1% (awarded a $170 mln project by Texas DOT) •$バイオジェン(BIIB.US)$+2.1% (Bi...
Greenback Stocks :
economy typically turns to tech to innovate out of slumps. but tech is being punished. what other tech can we rely? crypto! its been stable since August and we might see growth soon. keep eye on $ビットコイン (BTC.CC)$ and $イーサリアム (ETH.CC)$ and lunac. $Terra (LUNA.CC)$ investing in crytpo will eventually turn around tech and our economy. mark cuban was right!
Gainers: •$バリーズ・コーポレーション(BALY.US)$+6% (announces modified "Dutch auction" tender offer to purchase shares at $19.25-$22) •$ファーガソン(FERG.US)$+3.4% (enters entered into a non-discretionary arrangement with its brokers J.P. Morgan Securities in continuation of its $2 billion share repurchase program) •$ボシュ・ヘルス・カンパニーズ(BHC.US)$+3.3% (chairman resigns) •$サノフィ(SNY.US)$+3.2% (Sanofi-GSK first to report a successful efficacy study against ...
プリモリス・サービシズに関するコメント
コラムToday's Pre-Market Stock Movers: NIO, PATH, COUP, RKLB and More
In reaction to earnings/guidance:
• $Coupa Software(COUP.US)$ +12% (also authorizes new $100mln share repurchase program),$REVグループ(REVG.US)$ -5%,$G-IIIアパレル・グループ(GIII.US)$ + 2.1%,$ギットラブ(GTLB.US)$ +1.2%
Other news:
• $タッパーウェア・ブランズ(TUP.US)$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings(AVYA.US)$ +6.6% (authorizes workforce reduction plan)
• $バセット・ファニチャー・インダストリーズ(BSET.US)$ +5% (acqu...
コラムToday's pre-market stock movers: DASH, UBER, RKLB, BIIB and more
• $Resolute Forest Products(RFP.US)$ +65.7% (entered into an agreement under which Domtar will acquire all of the outstanding common shares of Resolute stock for $20.50 per share and one Contingent Value Right)
• $Applied Molecular(AMTI.US)$ +2.9% (to report top-line Phase 2 results from MARKET combination Trial of Oral AMT-101)
• $プリモリス・サービシズ(PRIM.US)$ +2.1% (awarded a $170 mln project by Texas DOT)
• $バイオジェン(BIIB.US)$ +2.1% (Bi...
コラムToday's pre-market stock movers: FDX, REV, BCS, KMX and more
• $バリーズ・コーポレーション(BALY.US)$ +6% (announces modified "Dutch auction" tender offer to purchase shares at $19.25-$22)
• $ファーガソン(FERG.US)$ +3.4% (enters entered into a non-discretionary arrangement with its brokers J.P. Morgan Securities in continuation of its $2 billion share repurchase program)
• $ボシュ・ヘルス・カンパニーズ(BHC.US)$ +3.3% (chairman resigns)
• $サノフィ(SNY.US)$ +3.2% (Sanofi-GSK first to report a successful efficacy study against ...
まだコメントはありません